MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Twist Bioscience Corporation - Common Stock (NQ:TWST)

49.82 +1.91 (+3.99%)
Streaming Delayed Price Updated: 1:52 PM EDT, Apr 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Twist Bioscience Corporation - Common Stock

< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
News headline image
The Week Ahead In Biotech (Nov. 21-Nov. 27): FDA Decisions, Earnings In The Spotlight In Holiday-Shortened Week ↗
Biotech stocks showed a lack of direction in the week ending Nov. 19 before finishing modestly higher. Stocks did not have much meaningful catalysts to react to amid the winding down of the reporting... 
Via Talk Markets
News headline image
The Week Ahead In Biotech (Nov. 21-Nov. 27): Takeda, Aadi, Fennec FDA Decisions, Earnings In The Spotlight In Holiday-Shortened Week ↗
Biotech stocks showed a lack of direction in the week ending Nov. 19 before finishing modestly higher. Stocks did not have much meaningful catalysts to react to amid the... 
Via Benzinga
News headline image
Earnings Preview For Twist Bioscience ↗
Twist Bioscience (NASDAQ:TWST) is set to give its latest quarterly earnings report on Monday, 2021-11-22. Here's what investors need to know before the announcement. Analysts... 
Via Benzinga
News headline image
Twist Bioscience Expands Partnership with Invetx to Include Discovery of Best-in-Class Antibodies to Treat Multiple Diseases in Cats and Dogs
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Launches Revelar Biotherapeutics to Develop and Commercialize Novel COVID-19 and Other Antibody Therapeutics for Difficult to Treat Diseases
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience to Present at the Stifel 2021 Virtual Healthcare Conference
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Named in Inc.’s First Annual Best-Led Companies List
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience to Report Fiscal 2021 Fourth Quarter and Full Year Financial Results on Monday, November 22, 2021
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Launches Exome 2.0 for Genomics Research
From Twist Bioscience Corporation
Via Business Wire
News headline image
Week In Review: Hansoh Signs $456 Million Deal For siRNA Products ↗
Hansoh Pharma of Shanghai announced a $456 million agreement to develop siRNA products in Greater China from South Korea's OliX Pharma. Hansoh will make an upfront payment of $6.5 million and up to... 
Via Talk Markets
News headline image
Twist Bioscience and the Broad Institute Create Custom Whole Exome Target Enrichment Panel for Clinical Research
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Appoints Steffen Hellmold as Senior Vice President, Business Development, Data Storage
From Twist Bioscience Corporation
Via Business Wire
News headline image
Centogene, Twist Join Forces For Custom Test Kits For Rare Diseases ↗
Centogene NV (NASDAQ: CNTG) and Twist Bioscience Corporation (NASDAQ: TWST) have signed a contract to develop and commercialize custom assay kits for rare diseases. The... 
Via Benzinga
News headline image
Twist Bioscience and CENTOGENE to Develop Advanced Sequencing Tools to Make Genetic Testing Rapidly Accessible for More Patients With Rare Diseases
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Expands Expert Custom Alliance Panel Offering
From Twist Bioscience Corporation
Via Business Wire
News headline image
Illumina Ventures Closes $325 Million Fund Supporting Start-ups in Healthcare Innovation
SOURCE: Illumina 
Via 3BL Media
News headline image
Twist Bioscience Appoints Dennis Cho as Senior Vice President, General Counsel and Chief Ethics and Compliance Officer
From Twist Bioscience
Via Business Wire
News headline image
Twist Bioscience Internally-Discovered Single Domain Antibody TB202-3 Shows Potent Binding to Multiple Strains of SARS-CoV-2, Including Alpha, Beta, and Gamma Strains, in Preclinical Studies
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Collaborates with Deep Learning Experts deepCDR on Antibody Library Design
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Continues Commitment to Deliver Synthetic RNA Controls, now to Fight Delta Plus Variants of COVID-19
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Collaborates with Adicet Bio to Accelerate Discovery of Gamma Delta T Cell Cancer Therapeutics
From Twist Bioscience Corporation and Adicet Bio
Via Business Wire
News headline image
Twist Bioscience, Boehringer Ingelheim Joins Forces For Antibody Research Programs ↗
Twist Bioscience Corporation (NASDAQ: TWST) has announced a broad-based research collaboration with Boehringer Ingelheim International GmbH. The collaboration... 
Via Benzinga
News headline image
Boehringer Ingelheim and Twist Bioscience Enter Therapeutic Antibody Discovery Collaboration
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience to Present at Baird 2021 Global Healthcare Conference
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience, SomaLogic Team Up For Antibodies, Target Discovery ↗
Twist Bioscience Corporation (NASDAQ: TWST) and SomaLogic announced a partnership to discover novel therapeutic targets and antibodies. Financial and other... 
Via Benzinga
News headline image
Twist Bioscience to Present at UBS Genomics 2.0 and Medtech Innovations Summit
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Corporation (TWST) Q3 2021 Earnings Call Transcript ↗
TWST earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
Twist Bioscience Stock Falls On Wider Q3 Loss, Sales Beat Estimates; Raises FY21 Guidance ↗
Twist Bioscience Corporation (NASDAQ: TWST) reported a 65% Y/Y increase in its third-quarter revenues to $35 million, beating the Wall Street estimate of $32.27 million... 
Via Benzinga
Topics Earnings
News headline image
Twist Bioscience: Q3 Earnings Insights ↗
Shares of Twist Bioscience (NASDAQ:TWST) remained unaffected after the company reported Q3 results. Quarterly Results Earnings per share were down 22.39% year over year to... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) Alkermes plc (NASDAQ: ALKS)... 
Via Benzinga
< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story